Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-03-03
2010-11-30
Sullivan, Daniel M (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C424S456000, C424S464000, C424S440000
Reexamination Certificate
active
07842679
ABSTRACT:
Taught are pharmaceutical compositions comprising at least one phospholipid having at least one docosahexaenoyl (DHA) residue, such as a lecithin-DHA-type phospholipid, and methods for treating or preventing respiratory failure of a patient comprising administering these pharmaceutical compositions to a patient in need of such treatment or prevention.
REFERENCES:
patent: 7074389 (2006-07-01), Frankenberger et al.
patent: 2 749 133 (1996-06-01), None
patent: 05-043456 (1993-02-01), None
patent: WO 02094283 (2002-11-01), None
Hashimoto et al., {1-Oleoyl-2-docosahexaenoyl phosphatidylcholine increased paradoxical sleep in F344 rats, Neuroscience letters 158, 1993, 29-32}.
Coste Thierry
Pieroni Gérard
Matthias Scholl, PC
Nwaonicha Chukwuma O
Scholl Matthias
Sullivan Daniel M
LandOfFree
Phospholipid derivatives of DHA and methods for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipid derivatives of DHA and methods for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipid derivatives of DHA and methods for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222137